← Back to S&P 500 Dashboard
ZTS
SELLZoetis Inc.
Healthcare · Rank #194 · Analyzed Oct 18, 2026
$79.38
Current Price
$61.75
Intrinsic Value
-22.2%
Upside/Downside
3/10
Score
3/5
Quality
Analysis Summary
Valuation Consensus0/2 methods agree
Quality Score3/5.0
Framework RatingSELL
Price vs Intrinsic ValueOvervalued by 22.2%
Fair Value Range
Low$59.55
Base (IV)$61.75
High$68.94
Entry Points
Conservative$41.69
Moderate$59.55
Aggressive$43.23
Quality & Moat Breakdown
Return on Equity64.9% → 1.0/1.0
Debt LevelD/E 294 → 0/1.0
Revenue QualityGrowth -2.4%, margin Δ+18.2% → 0/1.0
Moat Strength4.0/5 → 1.0/1.0
Profit Margins27.7% → 1.0/1.0
Methodology
This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.
Learn how this framework works →This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.